Resonex Ventures invests in OneVue to enhance global access to eye care through innovative telehealth solutions.

Information on the Target

OneVue is a pioneering technology company focused on enhancing access to eye care services globally. By leveraging advanced technology and innovative solutions, OneVue aims to streamline the process of ocular health assessment and treatment, making it more accessible to populations worldwide.

The company has developed a unique platform that integrates telemedicine with ophthalmic care, allowing patients to receive quality eye care remotely. This approach not only improves patient outcomes but also reduces the barriers associated with traditional in-person consultations.

Industry Overview in the Target’s Specific Country

The eye care industry in the United States is undergoing significant transformation, driven by advancements in technology and an increasing focus on patien

View Source

Similar Deals

S2G Investments Faeth Therapeutics

2025

Other VC Bio Therapeutic Drugs United States of America
Marlin Equity Partners Intelligent Locations

2025

Other VC Hospitals, Clinics & Primary Care Services United States of America
Rittenhouse Ventures S2N Health, Inc.

2025

Other VC Medical Software & Technology Services United States of America
Mubadala Capital Tenvie Therapeutics

2025

Other VC Bio Therapeutic Drugs United States of America
Comcast Ventures Sword Health

2025

Other VC Home Healthcare Services United States of America
Dental Innovation Alliance (DIA) Perceptive

2025

Other VC Advanced Medical Equipment & Technology (NEC) United States of America

Resonex Ventures

invested in

OneVue

in 2025

in a Other VC deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert